According to Insmed's latest financial reports the company's current EPS (TTM) is -$8.88. In 2022 the company made an earnings per share (EPS) of -$6.57 a decrease over its 2021 EPS that were of -$6.52.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$8.56 | 30.21% |
2022 | -$6.57 | 0.78% |
2021 | -$6.52 | 28.57% |
2020 | -$5.07 | -0.99% |
2019 | -$5.12 | -27.96% |
2018 | -$7.11 | 47.55% |
2017 | -$4.82 | 0.7% |
2016 | -$4.79 | 39.9% |
2015 | -$3.42 | 9.73% |
2014 | -$3.12 | 17.09% |
2013 | -$2.66 | 0.64% |
2012 | -$2.65 | -46.42% |
2011 | -$4.94 | 497.96% |
2010 | -$0.83 | -105.1% |
2009 | $16.19 | -850.78% |
2008 | -$2.16 | -24.71% |
2007 | -$2.86 | -71.67% |
2006 | -$10.11 | -28.57% |
2005 | -$14.16 | 23.53% |
2004 | -$11.46 | 134.48% |
2003 | -$4.89 | -73.64% |
2002 | -$18.54 | -2.65% |
2001 | -$19.04 | -86.64% |
2000 | -$142.58 |